Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aligos Therapeutics (ALGS) Cash from Operations (2021 - 2025)

Aligos Therapeutics filings provide 5 years of Cash from Operations readings, the most recent being 21745000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 18.16% to 21745000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 82503000.0, a 2.18% decrease, with the full-year FY2025 number at 82503000.0, down 2.18% from a year prior.
  • Cash from Operations hit 21745000.0 in Q4 2025 for Aligos Therapeutics, up from 24345000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 13616000.0 in Q2 2023 to a low of 37480000.0 in Q4 2021.
  • Median Cash from Operations over the past 5 years was 21327000.0 (2025), compared with a mean of 21864700.0.
  • Biggest five-year swings in Cash from Operations: skyrocketed 55.22% in 2022 and later crashed 43.16% in 2024.
  • Aligos Therapeutics' Cash from Operations stood at 37480000.0 in 2021, then skyrocketed by 55.22% to 16783000.0 in 2022, then plummeted by 35.01% to 22658000.0 in 2023, then grew by 18.78% to 18403000.0 in 2024, then fell by 18.16% to 21745000.0 in 2025.
  • The last three reported values for Cash from Operations were 21745000.0 (Q4 2025), 24345000.0 (Q3 2025), and 15504000.0 (Q2 2025) per Business Quant data.